Lifetech Scientific, a company out of Shenzhen, China, won CE Mark approval in Europe for its LAmbre left atrial appendage closure device.
The device is delivered via a 8-10 French sheath, and can be repositioned or fully removed as needed. It uses a patented anchoring mechanism for grabbing onto tissue.
According to Dr. David Change, the CTO of the firm, the LAmbre can be implanted regardless of the individual patient LAA anatomy
Lifetech is also working on obtaining FDA regulatory green light in the U.S. for the LAmbre.
Product page: LAmbre…
Via: LifeTech…